LAL test and RPT for endotoxin detection of CPT-11/DSPE-mPEG 2000 nanoformulation: What if traditional methods are not applicable?

Su, 2015, Methods of endotoxin detection, J Lab Autom, 20, 354, 10.1177/2211068215572136 Keith Esch, 2010, Endotoxin contamination of engineered nanomaterials, Nanotoxicology, 4, 73, 10.3109/17435390903428851 Li, 2016, Endotoxin contamination: A key element in the interpretation of nanosafety studies, Nanomedicine (Lond), 11, 269, 10.2217/nnm.15.196 Das, 2014, Recent advances in biosensor based endotoxin detection, Biosens Bioelectron, 51, 62, 10.1016/j.bios.2013.07.020 Pardo-Ruiz, 2016, Soluble β-(1,3)-glucans enhance lps-induced response in the monocyte activation test, but inhibit lps-mediated febrile response in rabbits: Implications for pyrogenicity tests, Eur J Pharm Sci, 81, 18, 10.1016/j.ejps.2015.09.018 Takahashi, 1983, A highly sensitive pyrogen test for antibiotics i: Detection of trace amounts of endotoxin in injectable sodium ampicillin preparations, J Pharm Sci, 72, 739, 10.1002/jps.2600720706 Unger, 2014, Human endothelial cell-based assay for endotoxin as sensitive as the conventional limulus Amebocyte lysate assay, Biomaterials, 35, 3180, 10.1016/j.biomaterials.2013.12.059 Chauhan, 2013, Strategies for advancing cancer nanomedicine, Nat Mater, 12, 958, 10.1038/nmat3792 Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat Nanotechnol, 2, 751, 10.1038/nnano.2007.387 Duncan, 2006, Polymer conjugates as anticancer nanomedicines, Nat Rev Cancer, 6, 688, 10.1038/nrc1958 Dobrovolskaia, 2015, Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy, J Control Release, 220, 571, 10.1016/j.jconrel.2015.08.056 Smulders, 2012, Contamination of nanoparticles by endotoxin: evaluation of different test methods, Part Fibre Toxicol, 9, 10.1186/1743-8977-9-41 Dobrovolskaia, 2013, 77 Bromberg, 2010, Binding of functionalized paramagnetic nanoparticles to bacterial lipopolysaccharides and DNA, Langmuir, 26, 8829, 10.1021/la904589p Darkow, 1999, Functionalized nanoparticles for endotoxin binding in aqueous solutions, Biomaterials, 20, 1277, 10.1016/S0142-9612(99)00022-8 Vetten, 2014, Challenges facing sterilization and depyrogenation of nanoparticles: Effects on structural stability and biomedical applications, Nanomedicine: Nanotechnology, Biology, and Medicine, 10, 1391, 10.1016/j.nano.2014.03.017 Dobrovolskaia, 2010, Ambiguities in applying traditional limulusAmebocyte lysate tests to quantify endotoxin in nanoparticle formulations, Nanomedicine (Lond), 5, 555, 10.2217/nnm.10.29 Dobrovolskaia, 2010, Ambiguities in applying traditional limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations, Nanomedicine: Nanotechnology, Biology, and Medicine, 5, 555, 10.2217/nnm.10.29 Li, 2016, Development and validation of a method for determination of encapsulation efficiency of CPT-11/DSPE-mPEG2000 nanoparticles, Medicinal Chemistry, 6, 345, 10.4172/2161-0444.1000368 Ahowesso, 2011, Sex and dosing-time dependencies in irinotecan-induced circadian disruption, Chronobiol Int, 28, 458, 10.3109/07420528.2011.569043 Jiang, 2011, Researches on bacterial endotoxin test for breviscapin injection, Drug Standards of China, 12, 430 Zhang, 2016, Study on pyrogen test method for amifostine, Chin J Pharm Anal, 36, 1299 Zhu, 1998, Discussion on dosage of pyrogen test, China Academic Journal, 12, 234